Siplizumab (CD2/LFA-2) - Research Grade Biosimilar, Unconjugated, Monoclonal

Artikelnummer: PRS-10-088
Artikelname: Siplizumab (CD2/LFA-2) - Research Grade Biosimilar, Unconjugated, Monoclonal
Artikelnummer: PRS-10-088
Hersteller Artikelnummer: 10-088
Alternativnummer: PRS-10-088-0.1
Hersteller: ProSci
Kategorie: Antikörper
Immunogen: Humanized / CD2/LFA-2 [Homo sapiens]
Konjugation: Unconjugated
Alternative Synonym: MEDI-507, CD2/LFA-2, CD2/LFA-2
Klonalität: Monoclonal
Konzentration: batch dependent
UniProt: P06729
Puffer: PBS buffer pH7.5
Quelle: CHO cells
Application Verdünnung: Optimal dilutions for each application to be determined by the researcher.